(Healthcare Radius) – Abbott, the global healthcare company, announced the launch of its laboratory-based blood test to evaluate mild traumatic brain injury (mTBI), commonly known as concussions.
The traumatic brain injury (TBI) test runs on Abbott’s Alinity i and Architect i1000SR laboratory instruments, which are available in major hospitals and laboratories such as Apollo, Hyderabad, and Neuberg Supratech Laboratory.
The test offers a reliable result in 18 minutes to help clinicians quickly evaluate brain injury and triage mTBI patients. The diagnostic tool also helps eliminate the need for CT scans by up to 40% with a high degree of certainty, eliminating wait time at the hospital and unnecessary exposure to radiation. CONTINUE